AAIC 2025 Abstract
EOAD‐Signature Atrophy Predicts Progression to Dementia in Patients with Early‐onset MCI due to Alzheimer’s Disease
Study in peopleBiomarkers
Abstract
Background: Prognostic risk stratification for patients at the mild cognitive impairment (MCI) stage of early‐onset Alzheimer’s disease (EOAD) would allow professionals and loved ones to make better‐informed medical and life planning decisions.



